Oncostatin-M in myocardial ischemia/reperfusion injury may regulate tissue repair

Croatian Medical Journal

Volumn 45, Issue 2, 2004, Pages 149-157

  Gwechenberger, Marianne ^a,c   Moertl, Deddo ^b   Pacher, Richard ^b   Huelsmann, Martin ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cell culture; Cytokines; Myocardial ischemia; Reperfusion injury

Indexed keywords

CYTOKINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; ONCOSTATIN M;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOG; ENDOTHELIUM CELL; FIBROBLAST CULTURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISCHEMIC HEART DISEASE; NONHUMAN; REPERFUSION INJURY;

ANIMALS; CELL DIVISION; CELLS, CULTURED; DOGS; ENDOTHELIAL CELLS; FIBROBLASTS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; ONCOSTATIN M; PEPTIDES;

EID: 2642558605     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ. Oncostatin-M: a growth regulator produced by different histiocytic lymphoma cells. Proc Natl Acad Sci USA. 1986;83:9739-43.
2. Taga T, Kishimoto T. GP 130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997;15:797-819.
3. Vernallis AB, Hudson KR, Heath JK. An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M. J Biol Chem. 1997;272:26947-52.
4. Kuropatwinski KK, De Imus C, Gearing D, Baumann H, Mosley B. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6. J Biol Chem. 1997;272:15135-44.
5. Auguste P, Guillet C, Fourcin M, Olivier C, Veziers J, Pouplard-Barthelaix A, et al. Signaling of type II oncostatin M receptor. J Biol Chem. 1997;272:15760-4.
6. Malik N, Kallestad JC, Gunderson NL, Austin SD, Neubauer MG, Ochs V, et al. Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol Cell Biol. 1989;9: 2847-53.
7. Bruce AG, Linsley P, Rose T, Oncostatin M. Prog Growth Factor Res. 1992;4:157-70.
8. Brown TJ, Lioubin MN, Marquardt H. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells. J Immunol. 1987;139:2977-83.
9. Brown TJ, Rowe JM, Liu JW, Shoyab M. Regulation of IL-6 expression by oncostatin-M. J Immunol. 1991;147: 2175-80.
10. Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH, et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation. 1999;99:546-51.
11. Malik N, Evans B, Greenfield BW, Shapiro RA, Hanson M, Shoyab M. Autocrine/paracrine induction of tissue inhibitor of metalloproteinase-1 in Chinese hamster ovary cells by oncostatin M. Matrix Biology. 1995;14: 677-80.
12. Richards CD, Shoyab M, Brown TJ, Gauldie J. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblast in culture. J Immunol. 1993;150:5596-603.
13. Michael LH, Lewis R, Brandon T, Entman ML. Cardiac lymph flow in the conscious dogs. Am J Physiol. 1979;237:H311-7.
14. Kukielka GL, Hawkins HK, Michael L, Manning AM, Youker K, Lane C, et al. Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. J Clin Invest. 1993;92:1504-16.
15. Zeng L, Takeya M, Takahashi K. AM-3K, a novel monoclonal antibody specific for tissue macrophages and its application to pathological investigation. J Pathol. 1996;178:207-14.
16. Zeng L, Takeya M, Ling X, Nagasaki A, Takahashi K. Interspecies reactivities of anti-human macrophage monoclonal antibodies to various animal species. J Histochem Cytochem. 1996;44:845-53.
17. Ford JW, Burkel WE, Kahn RH. Isolation of adult canine venous endothelium for tissue culture. In vitro. 1981; 17:44-50.
18. Kumar AG, Ballantyne CM, Michael LH, Kukielka GL, Youker KA, Lindsey ML, et al. Entman ML. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation. 1997;95:693-700.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162;156-9.
20. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1989 p. 545.
21. Vasse M, Pourtau J, Trochon V, Muraine M, Vannier JP, Lu H, et al. Oncostatin M induces angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol. 1999;19: 1835-42.
22. Modur V, Feldhaus MJ, Weyrich AS, Jicha DL, Prescott SM, Zimmerman GA, et al. Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest. 1997;100:158-68.
23. Grenier A, Dehoux M, Boutten A, Arce-Vicioso M, Durand G, Gougerot-Pocidalo MA, et al. Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood. 1999;93:1413-21.
24. Wallace PM, Macmaster JF, Rillema JR, Rouleau KA, Hanson MB, Burstein SA, et al. In vivo properties of oncostatin-M. Ann N Y Acad Sci. 1995;762:42-54.
25. Wallace PM, MacMaster JF, Rouleau KA, Brown TJ, Loy JK, Donaldson KL, Wahl AF. Regulation of inflammatory response by oncostatin M. J Immunol. 1999;162: 5547-55.
26. Wahl AF, Wallace PM. Oncostatin M in the anti-inflammatory response. Ann Rheum Dis. 2001;60 Suppl 3:iii75-80.
27. Richards CD, Langdon C, Botelho F, Brown TJ, Agro A. Oncostatin-M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor by synovial and lung fibroblasts. J Immunol. 1996;156: 343-9.
28. Yoshimura A, Ichihara M, Kinjyo I, Moriymam M, Copeland NG, Gilbert DJ, et al. A. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J. 1996;15: 1055-63.
29. Repovic P, Benveniste EN. Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia. J Neurosci. 2002;22:5334-43.
30. Guillet C, Fourcin M, Chevalier S, Pouplard A, Gascan H. ELISA detection of circulating levels of LIF, OSM, and CNTF in septic shock. Ann N Y Acad Sci. 1995;762:407-9.
31. Hurst SM, McLoughlin RM, Monslow J, Owens S, Morgan L, Fuller GM, et al. Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. J Immunol. 2002;169:5244-51.
32. Duncan MR, Hasan A, Berman B. Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts. J Invest Dermatol. 1995;104:128-33.
33. Liu J, Clegg CH, Shoyab M. Regulation of EGR-1, c-jun, and c-myc gene expression by oncostatin-M. Cell Growth Differ. 1992;3:307-13.
34. Horn D, Fitzpatrick WC, Gompper PT, Ochs V, Bolton Hansen M, Zarling J, et al. Regulation of cell growth by recombinant oncostatin M. Growth Factors. 1990;2: 157-65.
35. Eiken HG, Oie E, Damas JK, Yndestad A, Bjerkeli V, Aass H, et al. Myocardial gene expression of leukemia inhibitory factor, interleukin-6 and glykoprotein 130 in end-stage human heart failure. Eur J Clin Invest. 2001; 31:389-97.
36. Morita M, Kawashima S, Ueno M, Kubota A, Iwasaki T. Effects of late reperfusion on infarct expansion and infarct healing in conscious rats. Am J Pathol. 1993;143: 419-30.
37. Boyle MP, Weisman HF. Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model. Circulation. 1993;88:2872-83.
38. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Griffin GL, Senior RM, et al. Platelet derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol. 1989;109:429-40.
39. Pierce GF, Brown D, Mustoe TA. Quantitative analysis of inflammatory cell influx, procollagen type I synthesis, and collagen cross-linking in incisional wounds: influence of PDGF-BB and TGF-beta1 therapy. J Lab Clin Med. 1991;117;373-82.
40. Birdsall HH, Green DM, Trial J, Youker KA, Burns AR, MacKay CR, et al. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation. 1997;95: 684-92.
41. Hartner A, Goppelt-Struebe M, Hocke GM, Sterzel RB. Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M. Kidney Int. 1997;51:1754-60.
42. Ruprecht K, Kuhlmann T, Seif F, Hummel V, Kruse N, Bruck W, et al. Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. J Neuropathol Exp Neurol. 2001;60: 1087-98.
43. Kerfoot SM, Raharjo E, Ho M, Kaur J, Serirom S, McCafferty DM, et al. Exclusive neutrophil recruitment with oncostatin M in a human system. Am J Pathol. 2001;159:1531-9.
44. Bamber B, Reife RA, Haugen HS, Clegg CH. Oncostatin M stimulates excessive extracellular matrix accumulation in a transgenic mouse model of connective tissue disease. J Mol Med. 1998;76:61-9.
45. Hasegawa M, Sato S, Ihn H, Takehara K. Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis. Rheumatology (Oxford). 1999;38:612-7.
46. Levy MT, Trojanowska M, Reuben A. Oncostatin-M, a cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells. J Hepatol. 2000;32:218-26.
47. Sohara N, Trojanowska M, Reuben A. Oncostatin M stiumlates tissue inhibitor of metalloproteinase-1 via a MEK-sensitive mechanism in human myofibroblasts. J Hepatol. 2002;36:191-9.
48. Langdon C, Kerr C, Hassen M, Hara T, Arsenault AL, Richards CD. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am J Pathol. 2000;157:1187-96.
49. Scaffidi AK, Mutsaers SE, Moodley YP, McAnulty RJ, Laurent GJ, Thompson PJ, et al. Oncostatin-M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts. Br J Pharmacol. 2002;136:793-801.
50. Korzus E, Nagase H, Rydell R, Travis J. The mitogen-activated protein kinase and JAK-STAT signaling pathway are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem. 1997;272:1188-96.
51. Richards CD, Kerr C, Tanaka M, Hara T, Miyajima A, Pennica D, et al. Regulation of tissue inhibitor of metalloproteinase-1 in fibroblasts and acute phase proteins in hepatocytes in vitro by mouse oncostatin M, cardiotrophin-1 and IL-6. J Immunol. 1997;159:2431-7.
52. Lindsey M, Wedin K, Brown MD, Keller C, Evans AJ, Smolen J, et al. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation. 2001;103:2181-7.